Smartleaf Asset Management LLC Cytek Biosciences, Inc. Transaction History
Smartleaf Asset Management LLC
- $824 Billion
- Q3 2024
A detailed history of Smartleaf Asset Management LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 1,150 shares of CTKB stock, worth $7,429. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,150
Previous 526
118.63%
Holding current value
$7,429
Previous $2.89 Million
114.69%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CTKB
# of Institutions
135Shares Held
72.2MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$110 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$76.1 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$61.3 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$43 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$26.9 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $870M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...